AERIE PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2022.
  • Aerie Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2022 was 47.8M shares, a 3.19% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 46.3M shares, a 0.96% increase from 2020.
  • Aerie Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 45.9M shares, a 1.04% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 47.8M +1.48M +3.19% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 47.6M +1.37M +2.96% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 47.5M +1.41M +3.06% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 46.3M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 46.3M +397K +0.86% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 46.2M +322K +0.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 46.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 45.9M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 45.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.